Literature DB >> 8608631

Increased numbers of CD5+ B cells and T cell receptor (TCR) gamma delta+ T cells are associated with younger age of onset in rheumatoid arthritis (RA).

J Hassan1, G Yanni, V Hegarty, C Feighery, B Bresnihan, A Whelan.   

Abstract

Patients presenting with RA before the age of 45 years (younger onset) are known to have more aggressive disease compared with patients presenting after the age of 65 years (older onset). Coordinated expansion of circulating CD5+ B cell and TCR gamma delta+ T cell levels has been reported in patients with RA. This study assesses the peripheral blood levels of these two cell types in RA patients with younger and older onset of disease. CD5+ B cell levels were significantly elevated in the younger onset RA group (26.6+/-4.5%) compared with the older onset RA group (14.2+/-1.2%; P<0.01). TCR gamma delta+ T cell levels were also significantly raised in the young patients (4.0+/-0.9%) compared with elderly patients (1.6+/-0.2%; P<0.01). T cell levels (CD3+) were similar in both groups (young 66.4+/-3.3%; old 74.3+/-3.4% (mean+/-s.e.m.); NS). Total B cell levels (CD19+) were also similar in these groups (7.7+/-0.7% versus 8.9+/-1.8%; NS). A significant positive correlation was observed between the CD5+ B and TCR gamma delta+ T cell types in the patients (r=0.72, P<0.05). Compared with age-matched normal controls, the younger onset patients had similar CD5+ B cell and TCR gamma delta+ T cell levels to the elderly controls (CD5+ B cells 30.2+/-3.0%; TCR gamma delta+ T cells 3.0+/-0.8%). Conversely, older onset RA patients had CD5+ B cell levels similar to the young controls (12.3+/-1.9%). Spontaneous in vitro synthesis of immunoglobulins (IgM, IgA and IgG) and rheumatoid factors (IgM and IgA isotypes) were not significantly different in both patient groups. The coordinate expansion of circulating CD5+ B cells and gamma delta+ T cells seen in patients with RA presenting before 45 years of age and not after 65 years of age may suggest a potential role for these cells in more aggressive disease states.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8608631      PMCID: PMC2200359          DOI: 10.1111/j.1365-2249.1996.tb08287.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Isolation of CD4- CD8- mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid.

Authors:  J Holoshitz; F Koning; J E Coligan; J De Bruyn; S Strober
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

2.  Phenotypic and functional characterization of human Leu1 (CD5) B cells.

Authors:  N Gadol; K A Ault
Journal:  Immunol Rev       Date:  1986-10       Impact factor: 12.988

3.  T cell receptor expression and activation of synovial lymphocyte subsets in patients with rheumatoid arthritis. Phenotyping of multiple synovial sites.

Authors:  T Rème; M Portier; F Frayssinoux; B Combe; P Miossec; F Favier; J Sany
Journal:  Arthritis Rheum       Date:  1990-04

Review 4.  CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire.

Authors:  P Casali; A L Notkins
Journal:  Immunol Today       Date:  1989-11

5.  Coordinate expansion of 'fetal type' lymphocytes (TCR gamma delta+T and CD5+B) in rheumatoid arthritis and primary Sjögren's syndrome.

Authors:  F Brennan; C Plater-Zyberk; R N Maini; M Feldmann
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

6.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

7.  In vitro IgM and IgM rheumatoid factor production in response to Staphylococcus aureus Cowan I and pokeweed mitogen: the contribution of CD5+ (Leu 1) B cells.

Authors:  J Karsh; R Goldstein; A I Lazarovits
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

8.  Human gamma delta+ T cells respond to mycobacterial heat-shock protein.

Authors:  A Haregewoin; G Soman; R C Hom; R W Finberg
Journal:  Nature       Date:  1989-07-27       Impact factor: 49.962

9.  Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset.

Authors:  P Casali; S E Burastero; M Nakamura; G Inghirami; A L Notkins
Journal:  Science       Date:  1987-04-03       Impact factor: 47.728

10.  Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis.

Authors:  S E Burastero; P Casali; R L Wilder; A L Notkins
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

View more
  4 in total

Review 1.  T cell receptor usage in autoimmune disease.

Authors:  P Moss; J Bell
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Decreased Frequency of Intestinal Regulatory CD5+ B Cells in Colonic Inflammation.

Authors:  Yoshiyuki Mishima; Shunji Ishihara; Akihiko Oka; Nobuhiko Fukuba; Naoki Oshima; Hiroki Sonoyama; Noritsugu Yamashita; Yasumasa Tada; Ryusaku Kusunoki; Ichiro Moriyama; Takafumi Yuki; Kousaku Kawashima; Yoshikazu Kinoshita
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

3.  B1a cells play a pathogenic role in the development of autoimmune arthritis.

Authors:  Jun Deng; Xiaohui Wang; Qian Chen; Xiaoxuan Sun; Fan Xiao; King-Hung Ko; Miaojia Zhang; Liwei Lu
Journal:  Oncotarget       Date:  2016-04-12

4.  Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis.

Authors:  Steven K Lundy; David A Fox
Journal:  Arthritis Res Ther       Date:  2009-08-25       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.